Tower Research Capital LLC (TRC) - MONOPAR THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,311
-27.6%
3,727
-0.2%
0.00%
Q2 2023$3,192
+319100.0%
3,733
+423.6%
0.00%
Q1 2023$1
-85.7%
713
-74.8%
0.00%
Q4 2022$7
-99.9%
2,831
-9.6%
0.00%
Q3 2022$5,0000.0%3,131
+32.0%
0.00%
Q2 2022$5,000
-44.4%
2,372
-33.4%
0.00%
Q1 2022$9,000
+12.5%
3,560
+48.3%
0.00%
Q4 2021$8,000
-42.9%
2,401
+8.5%
0.00%
Q1 2021$14,000
+55.6%
2,212
+57.5%
0.00%
Q4 2020$9,000
-64.0%
1,404
-70.1%
0.00%
Q3 2020$25,0004,701
+6813.2%
0.00%
Q1 2020$0680.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
American Portfolios Advisors 700$1,7850.00%
ROYAL BANK OF CANADA 4,116$10,0000.00%
VANGUARD GROUP INC 99,879$255,0000.00%
UBS Group AG 3,106$8,0000.00%
FinTrust Capital Advisors, LLC 500$1,0000.00%
IFP Advisors, Inc 500$13,0000.00%
Glassman Wealth Services 1$00.00%
WELLS FARGO & COMPANY/MN 26$00.00%
NORTHERN TRUST CORP 35,207$90,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders